2021 annual financial data
Mirum Pharmaceuticals 2021 Operating margin
Direct answer
Operating margin was -906.12%.
Operating income was -173,413,000 USD and net income was -83,988,000 USD.
Operating cash flow was -132,758,000 USD.
Get free Mirum Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,138,000 USD
- Operating income
- -173,413,000 USD
- Net income
- -83,988,000 USD
- Operating cash flow
- -132,758,000 USD